Skip to content | Change text size

Information for Information about MCSS Home
 

Ronny Veljanovski

Ronny Veljanovski

Project Manager CRC-Biomedical Imaging Development Activities

B.Sc, PhD, GradCertTerEd, CertIVAppProjMan (currently completing)
Phone +61 (3) 9902 9796
Mobile +61 (4) 3337 5669

Email:ronny.veljanovski@sync.monash.edu.au

Dr Ronny Veljanovski is the Project Manager for the detectors stream of the CRC for Biomedical Imaging Development (CRCBID) R&D activities based Monash. The CRCBID was formally established in 2006 and aims to: develop new and advanced imaging techniques and equipment for applications in biomedicine; foster the growth of Australian expertise in biomedical imaging; and build the nation's capacity to serve needs of researchers, clinicians and industry working in the field. Monash University is a key participant of the CRCBID in which the entire detector R&D takes place. The other key participants are: ANSTO, Berthold, Cyclotek, Garvan Institute, GE Healthcare, Peter Mac Cancer Foundation and IBM (through a third party agreement).

Dr Veljanovski comes from a technical background in microelectronic engineering (60+ journal and conference publications) and has a strong management background in academic environments. He has managed industry and research projects, managed postgraduate programs in microelectronic engineering as well as general management in an academic and research environment.

Current projects:

Hybrid Pixel Detector

The Hybrid Pixel Detector is the top priority project from the CRC. It involves extensive research and development of novel X-ray detection techniques for CT scan and other radiographic applications. There are 4 sub projects that cover many facets of X-Ray detection such as system modelling, hardware simulations on a smaller scale, image reconstruction and visualisation and finally a complete detector prototype. The prototype currently being developed is of a novel CT (Computed Tomography) Detector that will provide higher contrast images at same radiation doses as current commercial CT's or provide the same contrast at reduced dosage levels.

PEDRO: Pixellated Emission Detector for RadioisotoPes

Diagnostic techniques for the measurement of the distribution of radiation in a patient.

The key benefits as a result of these projects will include:

  • Development of next generation biomedical imaging techniques and equipment providing improved medical diagnosis
  • Growth of an Australian expertise base and capacity to support the industrial, clinical and research human resource needs in biomedical imaging in Australia
  • Contributing to national research priorities; 1)Promoting and maintaining good health, and 2)Frontier technologies for building and transforming Australian industries